OBJECTIVES: This prospective, randomized controlled trial explored the feasibility and efficacy of a group program of mindfulness training, a cognitive-behavioral technique, for women with irritable bowel syndrome (IBS). The technique involves training in intentionally attending to present-moment experience and non-judgmental awareness of body sensations and emotions. METHODS:Seventy-five female IBS patients were randomly assigned to eight weekly and one half-day intensive sessions of either mindfulness group (MG) training or a support group (SG). Participants completed the IBS severity scale (primary outcome), IBS-quality of life, brief symptom inventory-18, visceral sensitivity index, treatment credibility scale, and five-facet mindfulness questionnaire before and after treatment and at 3-month follow-up. RESULTS:Women in the MG showed greater reductions in IBS symptom severity immediately after training (26.4% vs. 6.2% reduction; P=0.006) and at 3-month follow-up (38.2% vs. 11.8%; P=0.001) relative to SG. Changes in quality of life, psychological distress, and visceral anxiety were not significantly different between groups immediately after treatment, but evidenced significantly greater improvements in the MG than in the SG at the 3-month follow-up. Mindfulness scores increased significantly more in the MG after treatment, confirming effective learning of mindfulness skills. Participants' ratings of the credibility of their assigned interventions, measured after the first group session, were not different between groups. CONCLUSIONS: This randomized controlled trial demonstrated that mindfulness training has a substantial therapeutic effect on bowel symptom severity, improves health-related quality of life, and reduces distress. The beneficial effects persist for at least 3 months after group training.
RCT Entities:
OBJECTIVES: This prospective, randomized controlled trial explored the feasibility and efficacy of a group program of mindfulness training, a cognitive-behavioral technique, for women with irritable bowel syndrome (IBS). The technique involves training in intentionally attending to present-moment experience and non-judgmental awareness of body sensations and emotions. METHODS: Seventy-five female IBSpatients were randomly assigned to eight weekly and one half-day intensive sessions of either mindfulness group (MG) training or a support group (SG). Participants completed the IBS severity scale (primary outcome), IBS-quality of life, brief symptom inventory-18, visceral sensitivity index, treatment credibility scale, and five-facet mindfulness questionnaire before and after treatment and at 3-month follow-up. RESULTS:Women in the MG showed greater reductions in IBS symptom severity immediately after training (26.4% vs. 6.2% reduction; P=0.006) and at 3-month follow-up (38.2% vs. 11.8%; P=0.001) relative to SG. Changes in quality of life, psychological distress, and visceral anxiety were not significantly different between groups immediately after treatment, but evidenced significantly greater improvements in the MG than in the SG at the 3-month follow-up. Mindfulness scores increased significantly more in the MG after treatment, confirming effective learning of mindfulness skills. Participants' ratings of the credibility of their assigned interventions, measured after the first group session, were not different between groups. CONCLUSIONS: This randomized controlled trial demonstrated that mindfulness training has a substantial therapeutic effect on bowel symptom severity, improves health-related quality of life, and reduces distress. The beneficial effects persist for at least 3 months after group training.
Authors: Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin Journal: Gastroenterology Date: 2002-05 Impact factor: 22.682
Authors: W E Whitehead; R L Levy; M Von Korff; A D Feld; O S Palsson; M Turner; D A Drossman Journal: Aliment Pharmacol Ther Date: 2004-12 Impact factor: 8.171
Authors: D A Drossman; D L Patrick; W E Whitehead; B B Toner; N E Diamant; Y Hu; H Jia; S I Bangdiwala Journal: Am J Gastroenterol Date: 2000-04 Impact factor: 10.864
Authors: Douglas A Drossman; Brenda B Toner; William E Whitehead; Nicholas E Diamant; Chris B Dalton; Susan Duncan; Shelagh Emmott; Valerie Proffitt; Donna Akman; Karen Frusciante; Terry Le; Kim Meyer; Barbara Bradshaw; Kristi Mikula; Carolyn B Morris; Carlar J Blackman; Yuming Hu; Huanguang Jia; Jim Z Li; Gary G Koch; Shrikant I Bangdiwala Journal: Gastroenterology Date: 2003-07 Impact factor: 22.682
Authors: J S Labus; R Bolus; L Chang; I Wiklund; J Naesdal; E A Mayer; B D Naliboff Journal: Aliment Pharmacol Ther Date: 2004-07-01 Impact factor: 8.171
Authors: Elena Constantinou; Katleen Bogaerts; Lukas Van Oudenhove; Jan Tack; Ilse Van Diest; Omer Van den Bergh Journal: Int J Behav Med Date: 2015-08
Authors: Eric Manheimer; Ke Cheng; L Susan Wieland; Li Shih Min; Xueyong Shen; Brian M Berman; Lixing Lao Journal: Cochrane Database Syst Rev Date: 2012-05-16
Authors: Jeannie S Huang; Laura Terrones; Alan N Simmons; Walter Kaye; Irina Strigo Journal: J Pediatr Gastroenterol Nutr Date: 2016-11 Impact factor: 2.839
Authors: Wen Li; Eric L Garland; Patricia McGovern; Jennifer E O'Brien; Christine Tronnier; Matthew O Howard Journal: Psychol Addict Behav Date: 2017-04-24
Authors: S Jedel; A Hoffman; P Merriman; B Swanson; R Voigt; K B Rajan; M Shaikh; H Li; A Keshavarzian Journal: Digestion Date: 2014-02-14 Impact factor: 3.216
Authors: Yuko M Komesu; Rebecca G Rogers; Robert E Sapien; Ronald M Schrader; Timothy Simmerman-Sierra; Andrew R Mayer; Loren H Ketai Journal: Int Urogynecol J Date: 2016-10-17 Impact factor: 2.894